Renovaro logo

Renovaro share price today

(RENB)

Renovaro share price is $1 & ₹85.81 as on 7 Jan 2025, 2.30 'hrs' IST

$1

0.07

(7.99%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Renovaro share price in Dollar and Rupees. Guide to invest in Renovaro stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Renovaro, along with analyst recommendations, forecasts, and comprehensive financials.

Renovaro share price movements

  • Today's Low: $0.98
    Today's High: $1.24

    Day's Volatility :20.82%

  • 52 Weeks Low: $0.40
    52 Weeks High: $5.25

    52 Weeks Volatility :92.48%

Renovaro Returns

PeriodRenovaro IncIndex (Russel 2000)
3 Months
124.48%
0.0%
6 Months
-38.68%
0.0%
1 Year
-76.13%
0.0%
3 Years
-85.25%
-19.8%

Renovaro Key Statistics

in dollars & INR

Previous Close
$0.926
Open
$1.16
Today's High
$1.242
Today's Low
$0.9834
Market Capitalization
$132.6M
Today's Volume
$434.2K
52 Week High
$5.25
52 Week Low
$0.395
Revenue TTM
$0.0
EBITDA
$-27.3M
Earnings Per Share (EPS)
$-0.98
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-90.38%

How to invest in Renovaro from India?

It is very easy for Indian residents to invest directly in Renovaro from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Renovaro stock in both Indian Rupees (INR) and US Dollars (USD). Search for Renovaro or RENB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Renovaro or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Renovaro shares which would translate to 0.858 fractional shares of Renovaro as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Renovaro, in just a few clicks!

Returns in Renovaro for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Renovaro investment value today

Current value as on today

₹28,996

Returns

₹71,004

(-71%)

Returns from Renovaro Stock

₹74,227 (-74.23%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Renovaro

88%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Renovaro on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 88% more investors are searching Renovaro in the last 30 days versus the previous period.

Global Institutional Holdings in Renovaro

  • Vanguard Group Inc

    3.60%

  • BlackRock Inc

    2.30%

  • Geode Capital Management, LLC

    0.99%

  • State Street Corp

    0.83%

  • Northern Trust Corp

    0.37%

  • Morgan Stanley - Brokerage Accounts

    0.22%

Analyst Recommendation on Renovaro

Insights on Renovaro

  • Price Movement

    In the last 1 month, RENB stock has moved down by -47.7%
  • RENB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 98.5%
  • RENB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 141.6%

Renovaro Technicals Summary

Sell

Neutral

Buy

Renovaro is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Renovaro Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Renovaro Inc
-50.48%
-38.68%
-76.13%
-85.25%
-78.71%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Renovaro Inc
NA
NA
NA
0.0
-0.9
-0.15
NA
0.85
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Renovaro Inc
NA
$132.6M
-78.71%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Renovaro

enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company’s lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage, and its additional compounds eno-4001 (phase three asset), eno-4002, eno-5001, and eno-3001 are in discovery stages for prevention relapse in colon cancer patients. enochian biosciences is headquartered in los angeles, california.
Organization
Renovaro
Employees
25
CEO
Mr. Simon Tarsh
Industry
Miscellaneous

Management People of Renovaro

NameTitle
Mr. Simon Tarsh
Interim Chief Financial Officer
Dr. Francois Binette M.Sc., Ph.D.
COO and Executive VP for Research & Development
Mr. David H. Weinstein
CEO & Director
Dr. Serhat Gümrükcü
Co-Founder & Inventor
Mr. Greg Duczynski Ph.D.
Senior Vice President for Clinical Operations

Important FAQs about investing in Renovaro from India :

What is Renovaro share price today?

Renovaro share price today stands at $1.00, Open: $1.16 ; Previous Close: $0.93 ; High: $1.24 ; Low: $0.98 ; 52 Week High: $5.25 ; 52 Week Low: $0.40. The stock opens at $1.16, after a previous close of $0.93. The stock reached a daily high of $1.24 and a low of $0.98, with a 52-week high of $5.25 and a 52-week low of $0.40.

Can Indians buy Renovaro shares?

Yes, Indians can invest in the Renovaro (RENB) from India.

With INDmoney, you can buy Renovaro at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Renovaro at zero transaction cost.

How can I buy Renovaro shares from India?

It is very easy to buy Renovaro from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Renovaro be purchased?

Yes, you can buy fractional shares of Renovaro with INDmoney app.

What are the documents required to start investing in Renovaro stocks?

To start investing in Renovaro, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Renovaro

Today’s highest price of Renovaro (RENB) is $1.24.

Today’s lowest price of Renovaro (RENB) is $0.98.

What is today's market capitalisation of Renovaro

Today's market capitalisation of Renovaro RENB is 132.6M

What is the 52 Week High and Low Range of Renovaro

  • 52 Week High

    $5.25

  • 52 Week Low

    $0.40

What are the historical returns of Renovaro?

  • 1 Month Returns

    -50.48%

  • 3 Months Returns

    -38.68%

  • 1 Year Returns

    -76.13%

  • 5 Years Returns

    -78.71%

Who is the Chief Executive Officer (CEO) of Renovaro

Mr. Simon Tarsh is the current Chief Executive Officer (CEO) of Renovaro.